Your browser doesn't support javascript.
loading
Impact of transcatheter mitral valve edge-to-edge repair on atrial fibrillation burden: Insights from a multicenter cohort.
Trankle, Cory R; Rodriguez Lozano, Patricia F; Mahoney, Paul D; Haughey, Sean; May, Jennifer F; Rombaoa, Patricia; Miller, Lauren; Lim, Scott; Gertz, Zachary M.
Afiliação
  • Trankle CR; Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Rodriguez Lozano PF; Division of Cardiology, University of Virginia, Charlottesville, Virginia, USA.
  • Mahoney PD; Sentara Structural Heart Center, Norfolk, Virginia, USA.
  • Haughey S; Division of Cardiology, University of Virginia, Charlottesville, Virginia, USA.
  • May JF; Department of Internal Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
  • Rombaoa P; Sentara Health Research Center, Norfolk, Virginia, USA.
  • Miller L; Sentara Health Research Center, Norfolk, Virginia, USA.
  • Lim S; School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Gertz ZM; Division of Cardiology, University of Virginia, Charlottesville, Virginia, USA.
Pacing Clin Electrophysiol ; 46(2): 195-197, 2023 02.
Article em En | MEDLINE | ID: mdl-36450156
ABSTRACT

BACKGROUND:

Patients with significant mitralregurgitation (MR) often experience atrial fibrillation (AF). The effects of transcatheter edge-to-edge repair (TEER) for MR on AF burden is unknown.

METHODS:

Patients who underwent TEER atthree institutions who also had a cardiac implantable electronic device with aright atrial lead were retrospectively identified. In patients with baseline AF, device data onAF burden and echocardiographic changes were recorded at baseline and 3- and 12-month follow up time points when available. Data is expressed as number (%) and median (interquartile range), withpaired values analyzed using the Wilcoxon signed-rank test.

RESULTS:

Overall 66 patients wereidentified, of whom 54 (82%) had baseline data on AF available for review. Of these, 18 (33%) had a baseline burden ofAF (median burden 100% [54-100%]). Patients were 77 (71-83) years old, 10 (56%) male, 14 (78%) White, and 3 (17%) Black. A significant reduction in AF burdenwas observed at 3 months (11 patients, p = 0.03) which did not retainsignificance at 12 months (8 patients, p = 0.69). Indexed maximal left atrial volumes did not significantly change inthose with paired studies available (p > 0.35 for both time points).

CONCLUSIONS:

In this multicenter cohort, one thirdof patients with severe MR undergoing TEER had an AF burden at baseline, whichwas found to be significantly lower at 3 month follow up. Further investigation is needed to confirm thefindings of this small cohort and determine its effects on downstream sequelaeof AF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Implante de Prótese de Valva Cardíaca / Insuficiência da Valva Mitral Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Pacing Clin Electrophysiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Implante de Prótese de Valva Cardíaca / Insuficiência da Valva Mitral Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Pacing Clin Electrophysiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos